The crucial first step in managing cognitive problems is recognition and diagnosis, with baseline cognitive testing for screening or triage. Depending on the results, patients can be offered specialist assessment to define the cognitive problem more precisely (Lees et al, 2013) .
Standardized assessment batteries and cognitive screening tools play an important role in identifying underlying cognitive strengths and deficits in survivors of stroke (Van Heugten et al, 2015) . Previous studies have provided comprehensive comparisons of the utility and psychometric properties of such tools (Van Heugten et al, 2015) . One of the most widely used is the Montreal Cognitive Assessment (MoCA) (Nasreddine et al, 2005) . Burton and Tyson (2015) consider the MoCA "the most valid and clinically feasible screening tool to identify stroke survivors with a wide range of cognitive impairments." The Mini-Mental State Examination (MMSE) (Folstein et al, 1975) is widely used for quick dementia screening (Burton and Tyson, 2015) .
The MMSE and the majority of other screening tools used to assess post-stroke cognitive impairment were originally developed to assess age-related cognitive decline. Although they are now also used to screen stroke survivors, because of their original purpose, which focused on global impairments, they lack domain-specific items. This might explain why many such tools are unable to detect mild cognitive impairment, an intermediate clinical state that often progresses to dementia (Petersen et al, 1999) . Furthermore, there is no consensus on either a preferred tool to test for post-stroke cognitive impairment (Lees et al, 2013) or a preferred timing of assessment (Brainin et al, 2015) .
A screening tool for cognition in survivors of one or more left or right hemispheric strokes must first be able to discriminate between healthy people and those who have had a stroke (Chen et al, 2013) . Testing discriminant validity for a novel instrument will thus help clinicians interpret stroke survivors' performance.
The growing health care burden, and specifically the social and economic impact of post-stroke cognitive impairment, necessitates further clinical studies that go beyond discriminating between stroke and nonstroke to evaluating assessments and delineating their abilities to discriminate between people with and without post-stroke cognitive impairment. Studies are needed in both acute and long-term settings, to help clinicians plan and provide appropriate treatment throughout a patient's course (Brainin et al, 2015) .
The validity of future trials will depend on the ability to describe and quantify cognitive changes in stroke survivors. This ability, in turn, will depend on robust critical evaluations of the cognitive tests given to stroke survivors (Brainin et al, 2015; Quinn et al, 2009 ), as some commonly used tools may not be suitable for them (Godefroy et al, 2011) . Any appropriate test would have to be sensitive to common post-stroke impairments such as difficulties in executive functions; thus, the test should assess different cognitive domains.
A new domain-specific cognitive assessment tool is the Zu¨rich maxi mental status inventory, nicknamed the Zu¨MAX. It was developed by author P.B. at the Department of Neurology, University Hospital Zu¨rich, in 2012. His goal was to "maximize" the "Mini"-Mental State Examination, to create a neuropsychological screening instrument that would allow a fast (approximately 30 minutes) but highly sophisticated assessment of the cognitive domains of executive function, language, praxia, visuoperception and construction, and learning and memory. Although P.B. designed the Zu¨MAX to be a quick, convenient first test for patients with suspected neuropsychological deficits of any neurologic origin, the tool is also suitable for long-term follow-up. The actual instrument is described in the Methods section. P.B. modeled the Zu¨MAX on principles described by Schnider (2004) in his textbook on comprehensive yet time-efficient assessments in behavioral neurology. P.B. also incorporated suggestions from Hachinski et al (2006) that any neuropsychological screening instrument for vascular cognitive impairment include the domains of executive function, language, visuospatial perception and construction, and learning and memory. P.B. added the fifth domain, praxia, defined as the ability to perform purposeful actions, because this domain is typically affected by stroke (Buxbaum and Coslett, 2009) .
The Zu¨MAX has several advantages over both the MMSE and the MoCA. First, the Zu¨MAX examines the domains of perception and language in greater detail. Second, the Zu¨MAX tests praxia and executive function; the MMSE does not cover either of these domains, and the MoCA covers only executive function.
The Zu¨MAX has not yet been published (see "Limitations and Future Directions" in the Discussion section). Readers who want to learn more about the tool or request a research copy can write to Peter Brugger at peter.brugger@usz.ch.
The only existing evaluation of the Zu¨MAX is an unpublished 2014 master's thesis by Andrea Rust at the University of Zu¨rich (Rust, 2014) . Rust assessed norms and the construct validity of the Zu¨MAX compared with the MoCA and MMSE in 227 healthy adults. She found high correlations (P < 0.001) between the total scores of all the assessments.
The current study is the first peer-reviewed publication evaluating the Zu¨MAX. The tool has not been altered, meaning that we used the same version with our stroke survivors that Rust used in 2014.
Our purpose in this study was to evaluate whether the Zu¨MAX would be a valid and reliable assessment for measuring cognitive impairment in chronic stroke survivors. We aimed to evaluate not only test-retest reliability and smallest detectable difference (SDD), but also differences in scoring between chronic stroke survivors and healthy controls.
We hypothesized that the total score and the subscores for the five cognitive domains would have good relative reliability, with an intraclass correlation coefficient (ICC) Z0.80. Furthermore, we expected the SDDs (absolute reliability) to be r10% of the mean average values of the total score and subscores for the five cognitive domains. For discriminant validity, we expected to find significant group differences (P r 0.05) in the total scores and cognitive domain subscores.
METHODS

Participants
To recruit patients who had neurologic deficits after stroke, we contacted 40 outpatient occupational therapy practices in the canton of Bern, Switzerland. We asked the occupational therapists to refer patients currently or recently under their care, and we provided a list of admission criteria for screening the patients. Of the practices we contacted, 23 either had no access to stroke survivors or did not want to participate in the study. The remaining 17 practices, which regularly treated stroke survivors, each referred one to three patients to us between September 2013 and March 2014. (Unfortunately, no data are available about the patients who were approached but refused to participate.) Our study coordinator (author B.C.T.-A.) kept in touch with the participating occupational therapists to discuss the patients' eligibility and guarantee their privacy. Together, the examiner and therapist scheduled the appointments for the examiner to test the patients.
Through these means, we recruited a consecutive community-dwelling sample of 33 stroke survivors who met these eligibility criteria:
Age older than 18 years A stroke diagnosis, confirmed by a physician, at least 6 months before the study Ability to speak and understand the German language Ability to sit in a chair or wheelchair with a backrest for up to 60 minutes MMSE score Z20 (indicating, at worst, mild vascular dementia) for people younger than 80 years of age, and Z16 for people aged 80 years or older (Folstein et al, 1975; Tombaugh et al, 1996) Exclusion criteria were a diagnosis of a brain injury other than stroke, a physician's earlier diagnosis of neglect or aphasia, and a noncontrolled medical condition such as chronic pain or drug abuse.
We used the Flinders Handedness survey (FLAN-DERS) (Nicholls et al, 2013) to assess the patients' handedness.
We recruited a consecutive sample of healthy controls, whom we matched to the age and sex of the patients. To find the controls, we handed out participant information sheets to colleagues and relatives of the research team, with a request that they further disseminate the information to other people they knew (snowball sampling). We needed 33 controls, but this method was so successful that 35 people volunteered to take part. Because they fulfilled the inclusion criteria, we included all 35 in the control group.
The eligibility criteria for the controls were: Age older than 18 years No medical condition (such as a stroke or dementia) that could influence their cognitive skills Ability to speak and understand German
We asked the controls about their handedness, but we did not test it.
The study was approved by the Ethics Committee (Kantonale Ethikkommission [KEK]) (KEK-Nr. 119/13) of the Canton of Bern, Switzerland. All participants gave their informed consent before entering the study.
Zürich maxi mental status inventory (ZüMAX)
The Zu¨MAX is given as an interview. The total administration time of 30 minutes includes 5 minutes of instructions from the examiner. The examiner needs this equipment: a Zu¨MAX testing form with one coversheet, 24 stimulus cards (chimerical faces), and several demonstration, work, and record sheets; a stopwatch; a metronome; and a plain pencil (no eraser, no ruler) for patients to use.
Before starting the test, the interviewer assesses patients' orientation and obtains their demographic data, including education level. The interviewer also asks patients to score their mood on a visual analogue scale. The Zu¨MAX includes this "mood scale" (Figure 1) (Regard et al, 1982) because mood has a considerable impact on cognition (Kimura et al, 2000; Narushima et al, 2007) .
The Zu¨MAX profiles the five major cognitive domains typically covered in standard neuropsychological evaluations (Schnider, 2004) : language, praxia, learning and memory, visual perception and construction, and executive function. The five domains are assessed in 15 separate tasks, which are given in the following order and some of which we illustrate in this paper:
1 As noted, some of the tasks test several domains at once. For example, Figure 2 illustrates a task that assesses both language and praxia. Some tasks require spoken responses, and others require responses written or drawn with pencil and paper, using the dominant hand. Because many of the tasks are timed, the Zu¨MAX also addresses speed of information processing.
Participants can score a maximum of 6 points in each domain, with a total of 30 points representing optimal function for all five domains. Figure 3 shows the scoring for the domain of executive function and briefly explains the component tasks.
Immediately after completing the Zu¨MAX, the interviewer notes how long it took and characterizes both qualitatively and quantitatively the patient's orientation, alertness, tempo, ability to cooperate, affect, and communicative behavior.
Procedures
We assessed the patients in the stroke group either at their occupational therapist's clinic or in their home. We tested the patients twice. During the first session, we collected the demographic data and gave the MMSE and the FLANDERS. Then we administered the Zu¨MAX. As instructed, participants used their dominant hand to perform the writing and drawing tasks. During the second session, we repeated the Zu¨MAX. We spaced the two sessions about a week apart (mean 6.4 days ± 1.0 standard deviation) to minimize the effect of any learning or memory that might influence a patient's performance on the repeat test.
We did not try to give the patients a thorough neuropsychological evaluation. The patients' treating physician did not request this, and asking for such a service or providing it ourselves would have been beyond our scope.
After finishing the test-retest procedure with a patient, we recruited and tested an age-and sex-matched control participant. We tested the controls at a place of their choosing; most chose their home. At the controls' one testing session, we gathered their demographic data and asked about their handedness. We gave them the Zu¨MAX only once, to evaluate its discriminant validity.
The examiners were author B.C.T.-A. and master's student Judith Ha¨berli (J.H.). Author P.B. had trained them to administer the Zu¨MAX. The same examiner did the test and retest of an individual patient. The examiners divided up the testing of the controls depending on their availability.
Statistical Design
We used SPSS version 22.0 (SPSS Inc, Chicago, Illinois) for data management, and MedCalc statistical software version 14.8.1 (http://www.medcalc.org) to draw FIGURE 1. Affect: Self-reporting mood scale of the ZüMAX inventory, in English translation. Participants rate both their current mood and their best recollection of their affective state before they suffered their stroke. The examiner rates the value from À 6 to +6.
What finger movements does use of the black object require? (Demonstrate this by pantomime) FIGURE 2. Reading aloud and praxia: ZüMAX demonstration sheet for a task in the domains of language and praxia, in English translation. Participants are asked to read the instruction aloud and then act on it. Then they are given four more actions to pantomime, and must act on them.
Bland-Altman plots. We set the level of statistical significance at Pr0.05.
We used descriptive statistics to define the study population and their clinical characteristics. We calculated normality of the data using the Shapiro-Wilk test for small sample sizes (n < 50) (Norman and Streiner, 2008) . Our discriminant validity parameters were the subscores for the five cognitive domains and the total test score. We determined testing differences between the stroke and control groups with the Mann-Whitney U test (Norman and Streiner, 2008) .
We calculated effect size using the formula for nonparametric tests:
(Z being the converted U score) (Fritz et al, 2012) . We then used the effect size estimate r to calculate Cohen d value:
We calculated the 95% confidence intervals for effect size (Ivarsson et al, 2013 ). Cohen's (1988) guidelines for d and r are large effect (d = 0.80; r = 0.37), medium (d = 0.50; r = 0.24), and small (d = 0.20; r = 0.10).
We analyzed relative reliability by calculating ICCs separately for single measures using the ICC 2(A,1) formula (Shrout and Fleiss, 1979; Weir, 2005) . We selected the option "absolute agreement" to take into account the systematic error between raters B.C.T.-A. and J.H. (de Vet et al, 2006) . We used the following criteria for reliability: high, 0.90 to 0.99; good, 0.80 to 0.89; fair, 0.70 to 0.79; and poor, r0.69 (Arnall et al, 2002; Denegar and Ball, 1993) .
To calculate absolute reliability, we complemented the ICCs with Bland-Altman analysis, which can be used to show variation or the magnitude of difference of repeated measurements (Rankin and Stokes, 1998) . We measured the degree of heteroscedasticity by calculating the Kendall tau correlation between the absolute differences and the corresponding means of the reliability parameter. When we found a positive t > 0.1, we considered the data to be heteroscedastic. When the Kendall tau was <0.1 or negative, we considered the data homoscedastic (Brehm et al, 2012) . When we found heteroscedasticity, we transformed the data logarithmically (Bland and Altman, 1996; Euser et al, 2008) . Then we calculated the Kendall tau again; if t log decreased, we analyzed reliability using the log-transformed parameters (Brehm et al, 2012) .
To quantify the precision of individual scores on an assessment, we calculated the standard error of measurement (SEM) with the following formula:
p with s being the total variance of the scores from all participants (de Vet et al, 2006; Weir, 2005) . We then calculated the SDD based on the SEM:
Here 1.96 defines the 95% confidence interval. The factor ffiffi ffi 2 p is included because it concerns the difference between the two measurements.
As a last step, we calculated the SDD %:
The grand mean is the mean of the means of each Zu¨MAX parameter. Because agreement parameters (SDDs) are expressed on the actual scale of the assessments, they allow clinical interpretation of the results (de Vet et al, 2006; Weir, 2005) . The SDD % can be used to compare test-retest reproducibility among tests (Chen et al, 2009 ).
RESULTS
All patients and controls completed the study. Table 1 lists the participants' demographic and clinical characteristics. Of our 33 stroke survivors, 29 (87.8%) had suffered one stroke and four (three men and one woman) (12.1%) had sustained at least two strokes. Table 2 presents the two study groups' Zu¨MAX scores, including the total testing time and scores for selfevaluation of mood. The results of the Shapiro-Wilk test (Norman and Streiner, 2008) showed no normal distribution.
Discriminant Validity
In addition to the Zu¨MAX results, Table 2 presents the group differences. Descriptive statistics showed that the controls scored higher in all five cognitive domains and in the total score. For example, for the domain executive function, the patients' median and mean rank scores were 5 and 28.3 versus the controls' 6 and 40.3. The Mann-Whitney U value was significant: U = 369.5 (Z = 0.29), P = 0.004. The difference between groups was small: effect size r = 0.04; d = 0.08.
Overall, we found a significant difference between the two groups in three of the six measures: executive function, language, and total test score (P-values ranging from 0.001 to 0.004). The other three domains (praxia, visual perception and construction, and learning and memory) had no significant differences between the groups (P = 0.075 to 0.386). We found a small to medium effect size in the cognitive domains (r ranging from 0.04 to 0.22; d from 0.08 to 0.44) and a large effect size for the total score (r = 0.40, d = 0.95). Table 3 shows the test-retest reliability of the Zu¨MAX for the stroke group, and Figure 4 illustrates the findings in Bland-Altman plots.
Test-Retest Reliability
Our first hypothesis, about relative reliability (ICCZ0.80), was confirmed by virtue of the Zu¨MAX total score having an ICC of 0.81 (95% confidence interval: 0.64 to 0.90) (Table 3) . For subscores, the ICCs ranged from fair for executive function, language, and praxia (ICC = 0.72 to 0.79), to poor for visual perception and construction (0.59) and for learning and memory (0.60).
Our second hypothesis, concerning absolute reliability, was supported in four of the six Zu¨MAX measures: The SDDs for executive function, language, praxia, and total score (ranging from 0.05 to 1.49) were all r10% of the mean average values of the total score and subscores (Table 3 ). The SDDs of the two cognitive domains visual perception and construction (SDD = 2.16) and learning and memory (SDD = 1.97) exceeded the expected 10%, forcing us to reject the hypothesis. Calculating Kendall tau revealed that the three measures (executive function, praxia, and total test score) were heteroscedastic and therefore needed to be logarithmically transformed (Table 3) .
DISCUSSION
This study evaluated the discriminant validity and test-retest reliability of the novel cognitive assessment "Zu¨MAX" in survivors of stroke.
Validity
In the discriminant validity parameters with significant group differences, the stroke group scored on average 0.7 point lower than the controls for the domain language, 0.9 point lower for executive function, and 2.7 points lower for the total test score ( Table 2) . These results correspond in part to those of Kaya et al (2014) , who compared MoCA scores for 114 patients with mild cognitive impairment and 246 healthy controls. The authors reported that the most useful domains in discriminating mild cognitive impairment from normal cognition were recall, visuospatial, and language.
In the Zu¨MAX, however, the differences between groups were nonsignificant: only 0.1 point for praxia and 0.5 point each for visual perception and construction and for learning and memory. It is possible that by the time we Folstein et al, 1975. 3 Burton and Tyson, 2015. Tobler-Ammann et al Cogn Behav Neurol Volume 29, Number 2, June 2016 recruited our sample of stroke survivors, they had already recovered almost completely in these domains and thus reached near-perfect scores, creating a ceiling effect. A test is considered to have floor or ceiling effects if >15% of the respondents score the minimum or maximum (Terwee et al, 2007) . When we checked for such effects in the Zu¨MAX, we found no floor effects but we saw ceiling effects in all three cognitive domains with nonsignificant group differences. For praxia, for example, 84.9% of our stroke group scored the full 6 points, as did 91.4% of the controls. For the total score, 34.3% of the controls scored the full 30 points (and 25.7% reached 29 points), while only 6.1% of the stroke sample scored the maximum (and 30.3% reached 29 points). These ceiling effects make it impossible to distinguish among participants who had perfect scores, indicating limited validity.
Still, it seemed important for the Zu¨MAX to have a maximum of 6 points for each of the five relevant neuropsychological domains. This would make the total scale score of 30 points comparable to other cognitive screening instruments, especially the MMSE and MoCA, both of which also have a maximum score of 30. Before this scoring is made final for the Zu¨MAX, however, the scale should be examined in larger samples of stroke survivors and healthy controls, correcting for possible confounding factors such as cognitive status, to find out if ceiling effects remain.
We found that our stroke group needed on average of 5.1 minutes longer than the controls to perform the Zu¨MAX (Table 2 ). Needing more time to complete an assessment requires a longer period of concentration, disadvantageous in a population most of whose members 
Domain (Maximum Points)
Executive function (6) Language (6) Praxia (6) Visual perception and construction (6) Learning and memory (6) Total score ( likely have cognitive deficits (Van Heugten et al, 2015) . One reason for the prolonged test could be impairments in patients' information processing speed, a domain often affected after stroke (Edwards et al, 2013; Middleton et al, 2014) . Another reason is that 66% of our stroke sample had to perform the Zu¨MAX writing tasks using their affected hand as the dominant hand. Furthermore, the stroke group self-rated their mood an average of 0.5 point lower than the controls (Table 2 ). There is evidence that mood can affect cognition and that
Praxia
Visual perception and construction Learning and memory Total score depression is quite common after stroke (Kimura et al, 2000; Narushima et al, 2007) . This might explain our stroke sample's lower self-assessment on the mood scale and their slowed and less accurate test performance.
It is also well known that education has a main effect on cognitive assessment scores, while sex does not (Kaya et al, 2014) . We suggest correcting the Zu¨MAX for education effects, eg, by adding one point to the total score of participants who have at most 12 years of education, as is done with the MoCA (Nasreddine et al, 2005; Pendlebury et al, 2010) .
In our study, the control group was much more educated than the patients (Table 1) . We were unable to correct for these education differences, however, for two main reasons. First, our older participants in particular could not remember exactly how many years of education they had, and we were reluctant to include estimations in our study. Second, most participants, especially those with a university degree or apprenticeship, shared an attitude of life-long learning and had attended several continuing education programs, thus making it impossible for us to determine a true cutoff for years of education. To address this problem, we recommend considering education in the inclusion criteria of future studies.
Reliability
The Zu¨MAX showed fair to good reliability in four of the six measures, the exceptions being the domains visual perception and construction (ICC = 0.59) and learning and memory (ICC = 0.60). In the visual perception and construction domain, copying a 10-element figure ( Figure 5 ) may have been subject to learning effects despite our effort to prevent them by spacing the test and retest about a week apart. Likewise, in the learning and memory domain, the break between test sessions may not have been long enough to prevent a learning effect.
The other three cognitive domains (executive function, language, and praxia) and the total score, all of which had fulfilled our first hypothesis, had generally good test-retest reliability. Their low SDDs indicate that the Zu¨MAX is sensitive to individual change (Lexell and Downham, 2005) .
Our ICCs were lower than those of other cognitive assessments, eg, the MoCA. The MoCA's test-retest reliability for patients with cerebrovascular disease was good, ranging from 0.75 to 0.96 (Tu et al, 2013) . However, it is unclear which ICC formula Tu and colleagues applied in their statistics. This might be of importance in interpreting the results, as we used single measures (ICC 2,1 formula) to calculate our ICCs, which might have given us lower ICCs than if we had used averages for calculation (eg, ICC 2,k formula) (Shrout and Fleiss, 1979; Weir, 2005) .
Limitations and Future Directions
Our study had some limitations. First, we should emphasize that conclusions about the sensitivity of the Zu¨MAX must await larger investigations that include both a population with cognitive deficits and a comparable population of matched healthy participants.
Second, we could have used stricter inclusion and exclusion criteria to minimize heterogeneity between and within the stroke and control groups. For example, stricter criteria could distinguish between survivors of a first-ever or a recurrent stroke, as well as among patients with different subtypes of mild cognitive impairment (vascular, degenerative, mixed) . With stricter criteria, we could also stratify the sample by age group, education level, or time since stroke onset, and we could consider pre-stroke cognitive decline (Brainin et al, 2015) .
Third, accessing and assessing our patients' exact stroke diagnosis and medical history was difficult because some of the patients had suffered their stroke many years earlier.
A possible final limitation was our small sample size, which may have affected the values of reliability and measurement error. While the guidelines by Kottner et al (2011) would consider a sample size of 50 as adequate for our purpose, we think that our sample of 33 patients was of reasonable size in this first attempt to evaluate the general usefulness of the Zu¨MAX in patients with chronic stroke.
We see several directions for future research. One idea is to evaluate the value of the Zu¨MAX for patients during the acute phase of their stroke, or for an entirely different population, such as people with traumatic brain injury.
Cutoff scores have not yet been established for this novel instrument, unlike other similar tools such as the MMSE (Z24 points = normal according to Burton and Tyson, 2015) or the MoCA (>26 points = normal) Copy the geometric figure as well as you can and try to remember it! FIGURE 5 . Visuoconstruction and speed of information processing: ZüMAX worksheet for a task in the domain of visual perception and construction, in English translation. Participants are asked to copy the geometric figure as accurately as they can and to memorize it for later. They are told that "beauty doesn't matter." What does matter is that they draw the entire figure with all the parts in the right places and in approximately correct proportions. Participants earn one point for each of these elements: (1) the big rectangle, (2) a correctly placed small triangle, (3) the horizontal middle line, (4) the small rectangle on the far right side, (5) the "plus" sign in the upper left corner, (6) the three small diagonal lines in the lower left corner, (7) the oval, (8) the vertical line tangent to the left side of the oval, (9) the lower diagonal line, and (10) the upper diagonal line. One point is deducted for each markedly displaced or confabulated added element. (Dong et al, 2010; Nasreddine et al, 2005) . More work is required here. It would also be valuable to evaluate the Zü MAX's ecological validity, defined as the degree to which results obtained under experimental conditions relate to those obtained in natural environments (Tupper and Cicerone, 1990) . Chaytor and Schmitter-Edgecombe (2003) reviewed the research on ecological validity of neuropsychological tests, and concluded that many instruments offer moderate ability to predict patients' everyday cognitive function; the limitation of many tests is that they do not target individual cognitive domains that reflect specific aspects of daily function. However, it is unclear from the literature how strong the relationship between neuropsychological tests and measures of everyday function should be for a test to be considered ecologically valid.
To extend its reach, the Zu¨MAX could be digitized and integrated into a virtual exercise program for stroke survivors, allowing them to follow their progress when exercising independently at home so that they could further improve their upper limb motor and cognitive skills.
Finally, to increase awareness of the Zu¨MAX among clinicians, the tool should be translated into other languages. As of May 2016, author P.B. had written an English-language version of the test manual for clinicians, and he was planning a German-language publication on normative data for the Zu¨MAX in healthy adults. Author B.C.T.-A. had been involved with a Spanish-language translation, which was being tested in stroke survivors in Seville, Spain. There was no plan to publish the original German-language version of the test and manual.
In summary, the Zu¨MAX is a brief, yet comprehensive, domain-specific cognitive assessment for measuring disturbances of neuropsychological function in patients with chronic stroke. The instrument shows moderate to good reliability. In this preliminary study, the total test score showed better results than the subscores for the five single cognitive domains measured. The domains of executive function, language, and praxia showed fair reliability; the domains of learning and memory and of visual perception and construction showed poor reliability. As for discriminative validity, the Zu¨MAX might discriminate chronic stroke survivors from healthy controls on the three subscales of executive function, language, and learning and memory, as well as on the total score. In conclusion, our study indicates that the Zu¨MAX can be used as a single direct assessment to provide a "snapshot" of the current state of cognition in survivors of chronic stroke, but further research is required with larger sample sizes.
